These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
128 related items for PubMed ID: 579351
1. Thyroid autoimmune disease in a large Newfoundland family: the influence of HLA. Farid NR, Barnard JM, Marshall WH, Woolfrey I, O'Driscoll RF. J Clin Endocrinol Metab; 1977 Dec; 45(6):1165-72. PubMed ID: 579351 [Abstract] [Full Text] [Related]
3. The association of HLA with autoimmune thyroid disease in Newfoundland. The influence of HLA homozygosity in Graves' disease. Farid NR, Barnard JM, Marshall WH. Tissue Antigens; 1976 Sep; 8(3):181-9. PubMed ID: 989647 [Abstract] [Full Text] [Related]
4. A study of human leukocyte D locus related antigens in Graves' disease. Farid NR, Sampson L, Noel EP, Barnard JM, Mandeville R, Larsen B, Marshall WH, Carter ND. J Clin Invest; 1979 Jan; 63(1):108-13. PubMed ID: 105012 [Abstract] [Full Text] [Related]
8. Class III alleles and high-risk MHC haplotypes in type I diabetes mellitus, Graves' disease and Hashimoto's thyroiditis. Skanes VM, Barnard J, Farid N, Marshall WH, Murphy L, Rideout D, Taylor R, Xidos G, Larsen B. Mol Biol Med; 1986 Apr; 3(2):143-57. PubMed ID: 3461234 [Abstract] [Full Text] [Related]
9. The role of HLA antigens in the manifestation and course of Graves' disease. Stenszky V, Kozma L, Balazś C, Bear JC, Farid NR. Mol Biol Med; 1986 Feb; 3(1):53-62. PubMed ID: 3485758 [Abstract] [Full Text] [Related]
10. Major histocompatibility complex (MHC) factors predisposing to and protecting against Graves' eye disease. Frecker M, Mercer G, Skanes VM, Farid NR. Autoimmunity; 1988 Feb; 1(4):307-15. PubMed ID: 2979624 [Abstract] [Full Text] [Related]
11. The genetics of Graves' disease: HLA and disease susceptibility. Stenszky V, Kozma L, Balázs C, Rochlitz S, Bear JC, Farid NR. J Clin Endocrinol Metab; 1985 Oct; 61(4):735-40. PubMed ID: 3861611 [Abstract] [Full Text] [Related]
12. [HLA B8 and Graves' disease (author's transl)]. Jaffiol C, Seignalet J, Baldet L, Robin M, Lapinski H, Mirouze J. Ann Endocrinol (Paris); 1976 Oct; 37(4):219-26. PubMed ID: 1037358 [Abstract] [Full Text] [Related]
13. HLA haplotypes and susceptibility to Graves' disease. De Rosa G, Testa A, Mariani M, Purpura M, Giacomini D. Horm Res; 1992 Oct; 37(4-5):176-9. PubMed ID: 1490660 [Abstract] [Full Text] [Related]
14. Graves' disease and HLA: clinical and epidemiologic associations. Farid NR, Stone E, Johnson G. Clin Endocrinol (Oxf); 1980 Dec; 13(6):535-44. PubMed ID: 6894412 [Abstract] [Full Text] [Related]
15. HLA and Graves' disease: an association with HLA-DRw3. Allannic H, Fauchet R, Lorcy Y, Heim J, Gueguen M, Leguerrier AM, Genetet B. J Clin Endocrinol Metab; 1980 Oct; 51(4):863-7. PubMed ID: 6932402 [Abstract] [Full Text] [Related]
17. HLA antigens and thyroid autoantibodies in patients with Graves' disease and their first degree relatives. Mather BA, Roberts DF, Scanlon MF, Mukhtar ED, Davies TF, Smith BR, Hall R. Clin Endocrinol (Oxf); 1980 Feb; 12(2):155-63. PubMed ID: 6893172 [Abstract] [Full Text] [Related]
18. Polymorphism of the fourth component of complement in Graves' disease and type I diabetes mellitus. Skanes V, Larsen B, Sampson-Murphy L, Farid NR. Clin Invest Med; 1985 Feb; 8(2):126-32. PubMed ID: 3869086 [Abstract] [Full Text] [Related]
19. The CTLA4 region as a general autoimmunity factor: an extended pedigree provides evidence for synergy with the HLA locus in the etiology of type 1 diabetes mellitus, Hashimoto's thyroiditis and Graves' disease. Einarsdottir E, Söderström I, Löfgren-Burström A, Haraldsson S, Nilsson-Ardnor S, Penha-Goncalves C, Lind L, Holmgren G, Holmberg M, Asplund K, Holmberg D. Eur J Hum Genet; 2003 Jan; 11(1):81-4. PubMed ID: 12529710 [Abstract] [Full Text] [Related]